A diselenide MOF-based nanomotor dual-driven by carbon monoxide and near-infrared-II light for multimodal tumor-targeted therapy
Ruizhen Tian,Zherui Zhang,Liping Song,Yijia Li,Zhengwei Xu,Wang Liu,Tianlong Zhang,Jiayun Xu,Youju Huang,Tingting Wang,Xiaotong Fan,Junqiu Liu
DOI: https://doi.org/10.1007/s11426-024-2331-y
2024-11-10
Science China Chemistry
Abstract:The dense extracellular matrix and high interstitial pressure within tumors hinder nanoparticle penetration, reducing therapeutic efficacy. To address this, we engineered a dual-driven nanomotor based on a diselenide metal-organic framework (MOF) using a layer-by-layer assembly process for multimodal synergistic tumor therapy. Diselenide-containing imidazole derivatives coordinated with Zn 2+ form the MOF, sequentially encapsulating near-infrared-II (NIR-II) photothermal-responsive gold nanorods (AuRods), Mn 2 CO 10 (MnCO), and glucose oxidase (GOD). The nanoparticle surface was functionalized with 4T1 cancer cell membranes (DSACGM NPs), guiding it to drive toward the tumor site. The photothermal effect of AuRods and CO release drives nanomotor propulsion, enhancing tumor tissue penetration. GOD catalyzes glucose (Glu) oxidation, inducing tumor starvation, while the resulting H 2 O 2 triggers CO release, suppressing heat shock protein (HSP) expression and enhancing mild photothermal therapy (PTT). The release of CO and the Mn 2+ -triggered Fenton-like reaction from MnCO increased intracellular ROS levels, while diselenide depletion of glutathione (GSH) amplified chemodynamic therapy (CDT). In vitro and in vivo experiments show that DSACGM NPs induce cancer cell apoptosis under NIR-II irradiation and efficiently ablate tumors in mice at sub-hyperthermic temperatures (<45°C) with excellent biocompatibility. This study provides valuable insights into nano-medicine design and its potential in advanced tumor therapies.
chemistry, multidisciplinary